Your browser doesn't support javascript.
loading
In vitro prediction of the efficacy of molecularly targeted cancer therapy by Raman spectral imaging.
Yosef, Hesham K; Mavarani, Laven; Maghnouj, Abdelouahid; Hahn, Stephan; El-Mashtoly, Samir F; Gerwert, Klaus.
Afiliação
  • Yosef HK; Department of Biophysics, Ruhr University Bochum, Universitätsstr. 150, 44780, Bochum, Germany.
  • Mavarani L; Department of Biophysics, Ruhr University Bochum, Universitätsstr. 150, 44780, Bochum, Germany.
  • Maghnouj A; Department of Molecular GI-Oncology, Clinical Research Center, Ruhr University Bochum, Universitätsstr. 150, 44780, Bochum, Germany.
  • Hahn S; Department of Molecular GI-Oncology, Clinical Research Center, Ruhr University Bochum, Universitätsstr. 150, 44780, Bochum, Germany.
  • El-Mashtoly SF; Department of Biophysics, Ruhr University Bochum, Universitätsstr. 150, 44780, Bochum, Germany.
  • Gerwert K; Department of Biophysics, Ruhr University Bochum, Universitätsstr. 150, 44780, Bochum, Germany. gerwert@bph.rub.de.
Anal Bioanal Chem ; 407(27): 8321-31, 2015 Nov.
Article em En | MEDLINE | ID: mdl-26168967
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Análise Espectral Raman / Colo / Neoplasias do Colo / Resistencia a Medicamentos Antineoplásicos / Receptores ErbB / Cloridrato de Erlotinib / Antineoplásicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Análise Espectral Raman / Colo / Neoplasias do Colo / Resistencia a Medicamentos Antineoplásicos / Receptores ErbB / Cloridrato de Erlotinib / Antineoplásicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article